Pharmacovigilance Literature Monitoring

Our pharmacovigilance literature monitoring solution offers a modular, end-to-end approach to literature surveillance for pharmacovigilance. It gives any organisation tasked with drug safety reporting a streamlined, efficient and compliant approach to the entire literature triage process. 

Get in touch with us today to discuss how we can improve your approach to pharmacovigilance literature surveillance, or take a look at the free resources below. 

At every stage of the medical literature monitoring process, we help the world’s biggest pharmaceutical companies save time and money. Using our pharmacovigilance literature monitoring solution, our customers are able to: 

%

Shorten drug alert set up time by 80%

%

Decrease the time spent monitoring literature for aggregate reports and safety signals by 80%

%

Cut in half the time it takes literature reviewers to monitor literature for ICSRs

Pharmacovigilance Literature Monitoring with Dialog Solutions

Pharmaceutical companies of all sizes, contract research organisations, medical device manufacturers, biotech and biopharma firms use our drug safety literature screening solution to identify and review articles for relevant ICSRs, aggregate reports (including PBRER, PSUR and DSUR) and safety signals.

Our modular, end-to-end approach to drug safety reporting means we can improve every element of this process:

Content

We provide access to all essential content databases for pharmacovigilance through the Dialog® platform.

Dialog®

The Dialog® platform delivers a consistent search experience across multiple databases, ensuring all relevant drug safety results are identified. Our Literature Search Services team can also create custom, regulatory compliant drug safety search strategies for your medical literature monitoring workflow. 

Dialog® Alerts Manager

The Dialog® Alerts Manager simplifies the process of automating and managing multiple drug safety searches in Dialog. It also provides a range of features to meet the expectations of regulators and inspectors, including a range of alert frequencies (4 hours, daily, weekly, or every 1, 3, 6 or 12 months).

Drug Safety Triager

Literature articles retrieved by the Dialog Alerts Manager are integrated directly into Drug Safety Triager, our fully-validated, flagship drug safety triage tool. The system streamlines the literature monitoring workflow by eliminating duplicated content, reducing the volume of literature to be reviewed and automatically outputs literature references relevant to patient safety issues.

Our machine learning model makes the literature analysis even more efficient by helping the reviewers prioritise their work and focus on the drug safety elements of analysed articles.

Literature Screening Services

Our literature monitoring team helps our customers with critical, time-consuming and resource-intensive tasks within the drug safety monitoring workflow.

Dialog Solutions Pharmacovigilance Literature Monitoring Features and Benefits:

Comprehensive literature coverage

We provide access to over 140 content databases, including MEDLINE, Embase and Biosis. We also standardise all our medical literature database content to provide a consistent search experience, eliminating the need for complex post processing.

PRECISION SEARCH

Through our search platform Dialog, we offer precision search in our medical literature databases. Search results are output into a native XML format so they can be integrated seamlessly into drug safety reporting ecosystems.

Improved Efficiency

Drug Safety Triager, our validated pharmacovigilance literature triage solution, delivers measurable efficiency and cost savings, while increasing productivity and compliance. The automated workflow ensures all articles are methodically ingested, processed and outputted for drug safety issues.

Advanced search management

The search and alerts manager built into our pharmacovigilance monitoring solution makes it easier to manage and schedule multiple drug safety searches.

Artificial Intelligence

Our medical literature monitoring solution uses machine learning to improve the quality, speed and efficiency of the literature review process by automatically identifying articles that qualify as ICSRs.

Validated and compliant

Our medical literature monitoring solution is fully validated and compliant with the reporting requirements of global safety bodies, including the FDA, EMA and PMDA. 

Streamline Your Medical Literature Monitoring: Free Resources

Pharmacovigilance Literature Screening: Best Practice Checklist

Click the button below to download our exclusive, 18-step best practice guide for optimising your drug safety literature screening process. 

Webinar: Manage growing literature review workloads with pharmacovigilance automation and integration

Literature review teams in drug safety departments are overloaded with a rising tide of work and decreasing budgets. The number of adverse events being reported is growing year on year, along with the amount of literature that needs to be monitored. For drug safety teams, this pace isn't sustainable; they either need to employ more reviewers or run the risk of valid ICSRs being missed by...

Dialog Alerts: Delivering Relevant Pharmacovigilance Literature Alerts for Drug Safety Aggregate Reports

Dialog alerts are a central part of our pharmacovigilance literature monitoring solution. They ensure key medical literature is automatically searched on a regular, predictable basis to deliver relevant journal articles for drug safety monitoring. An important part of this is the creation of aggregate reports, used by pharmaceutical and medical device companies for product authorization and...

[VIDEO] How to deploy resources effectively in pharmacovigilance literature monitoring

When it comes to identifying patient safety issues relating to drugs, scientific and medical literature is a crucial resource. Get pharmacovigilance literature monitoring wrong, and you could draw the wrong conclusions about patient safety issues – or delay making decisions – in a way that could lead to patients being harmed. The challenge is knowing how to deploy literature monitoring resources...

How our end-to-end pharmacovigilance literature monitoring works [VIDEO]

At Dialog Solutions, we work with some of the world’s biggest pharmaceutical companies to deliver modular, end-to-end medical literature monitoring for pharmacovigilance. What’s more, we’re the only organisation that offers a truly end-to-end approach to drug safety literature monitoring. We provide the content (including the top biopharma collections), software (Dialog with Alerts Management...

Why Quality Management and Validation Matter for Medical Literature Monitoring

“It is not enough to do your best; you must know what to do, and then do your best”. So said W. Edwards Deming, quality guru and founder of the concept of continuous improvement that transformed Japanese industry after World War II. With this maxim, Deming captured the essence of Quality* management and validation in the medical literature monitoring (MLM) software that is used in...

How to Reduce Missed Drug Safety References with Precision Search

Can a single missed drug safety reference be a billion dollar problem? If it’s been missed in literature monitoring for pharmacovigilance, it can. A missed drug safety reference can have serious consequences, with PV professionals making the wrong conclusions and patients being harmed, prompting lawsuits, regulatory action and precipitous share price falls. But when marketing authorisation...

Doing It Right: The Rigorous Approach to Medical Literature Monitoring for Drug Safety

Correctly identifying adverse events from medical literature is one of the key tasks in pharmacovigilance (PV). It’s also one of the most complex. The sheer volume of information available is overwhelming: so much so that even in the most precisely constructed searches, only five percent of references retrieved will be relevant. Then there’s the issue of duplicate articles, which on average,...

You Need to Reduce Duplicate References in Your Medical Literature Monitoring: Here’s Why

Too much information. In our everyday lives it’s an irritation, at worst. But in medical literature monitoring, it’s a major issue. How do you cut through the noise to find the reference that really matters? In our paper Better Relevance, we discussed how precision search can cut down the volume of alerts relevant to adverse events by 30-50%. But this alone doesn’t solve the information overload...

Can AI and machine learning automate medical literature monitoring?

If you work in pharmacovigilance (PV), are the robots coming for your job? Medical literature monitoring is part of the PV process with significant scope for automation. On the face of it, this seems an obvious insight. Literature monitoring ticks all the boxes for needing to be automated. It can be repetitive, time-consuming work that ties up experts who could be spending more time on patient...

Medical literature monitoring case study: Taking an end-to-end approach

"The Dialog Drug Safety Triager has enabled us to save time, introduce multiple efficiencies and switch outsource partners with no disruption. I would highly recommend it.”   The Brief We were approached by a top ten pharmaceutical organisation to streamline its global medical literature monitoring for drug safety. Tired of managing multiple systems and sources, it wanted to move forward with...

Video Series: End-to-end literature monitoring in pharmacovigilance with Dialog Solutions

Take a look at these three short videos to see exactly how our end-to-end solution for medical literature monitoring works in practice. Between the three videos, you’ll get a better understanding of:

 

 

On-Demand Webinar: Three Ways To Improve Your Approach to Pharmacovigilance Literature Screening

Our on-demand webinar looks at three key areas in medical literature monitoring – search, duplicate references and quality and validation – and provides advice and guidance on how you can optimise each of these elements in your medical literature monitoring process. By the end of the webinar you’ll have a better understanding of the impact search strategies, duplicate references and validated software has on the efficiency and effectiveness of your medical literature monitoring workflow.

Dialog Biomedical Databases:

Access the MEDLINE database with Dialog

Access MEDLINE, the U.S. National Library of Medicine's premier bibliographic database, through the Dialog platform. By searching the MEDLINE database directly through the Dialog platform, you can...

read more

ProQuest Dissertations & Theses Global

ProQuest Dissertation & Theses Global is a comprehensive collection of multi-disciplinary dissertations and theses from around the world. It provides access to over 5 million citations and 2.7...

read more

Search Embase with Dialog

Search Embase, the biomedical and pharmacological database, through the Dialog platform. By accessing Embase directly through Dialog, you can take advantage of our flexible pricing options, powerful...

read more

Health Research Full Text Professional

In the medical field, access to the latest healthcare information is always essential, whether it’s for students, researchers, medical professionals, hospital administrators, or even for patients...

read more

Search BIOSIS Previews on Dialog

Search BIOSIS Previews, the life sciences and biomedical research database, through the Dialog platform. By accessing BIOSIS Previews directly through Dialog, you can take advantage of our...

read more

AdisInsight: Drugs

AdisInsight: Drugs (formerly Adis R&D Insight) provides leading, evidence-based scientific and market information on drugs in commercial development worldwide. Drug and cell-based products are...

read more

Get In Touch

We can help with all elements of medical literature monitoring for pharmacovigilance, saving you time and money as well as improving regulatory compliance and reducing the risk of missing patient safety alerts. Contact us using the button below to see how we can support you.